Recent advances in the management of chronic obstructive pulmonary disease.

about

Toll-like receptors-mediated pathways activate inflammatory responses in the esophageal mucosa of adult eosinophilic esophagitis.

P2860

Q53821621-E65DF75F-E66F-403C-BCB0-4C3F1853FC4B

P2860

Recent advances in the management of chronic obstructive pulmonary disease.

Item

http://www.wikidata.org/entity/Q38701325

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Recent advances in the management of chronic obstructive pulmonary disease.

@en

type

Item

label

Recent advances in the management of chronic obstructive pulmonary disease.

@en

prefLabel

Recent advances in the management of chronic obstructive pulmonary disease.

@en

P1476

Recent advances in the management of chronic obstructive pulmonary disease.

@en

P2093

Sharon R Rosenberg

http://www.w3.org/2001/XMLSchema#string

P2860

Projections of global mortality and burden of disease from 2002 to 2030

Diagnosis and Management of Stable Chronic Obstructive Pulmonary Disease: A Clinical Practice Guideline Update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society

Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease

Safety and tolerability of once-daily umeclidinium/vilanterol 125/25 mcg and umeclidinium 125 mcg in patients with chronic obstructive pulmonary disease: results from a 52-week, randomized, double-blind, placebo-controlled study

A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease

Advances in pulmonary laboratory testing.

Efficacy and safety of olodaterol once daily delivered via Respimat® in patients with GOLD 2-4 COPD: results from two replicate 48-week studies.

Withdrawal of inhaled corticosteroids can be safe in COPD patients at low risk of exacerbation: a real-life study on the appropriateness of treatment in moderate COPD patients (OPTIMO)

P304

863

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.12688/F1000RESEARCH.9819.1

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ravi Kalhan

P577

2017-06-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28663790

http://www.w3.org/2001/XMLSchema#string

P921

chronic obstructive pulmonary disease

P932

5473415

http://www.w3.org/2001/XMLSchema#string

Recent advances in the management of chronic obstructive pulmonary disease.

about

P2860

P2860

Recent advances in the management of chronic obstructive pulmonary disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P921

P932